Treatment With Dasatinib or Nilotinib in Chronic Myeloid Leukemia Patients Who Failed to Respond to Two Previously Administered Tyrosine Kinase Inhibitors - a Single Center Experience . Clinics 2015, 70 (8), 550-555. https://doi.org/10.6061/clinics/2015(08)04.